Literature DB >> 10331598

Mosaicism in a fragile X male including a de novo deletion in the FMR1 gene.

E Petek1, P M Kroisel, M Schuster, H Zierler, K Wagner.   

Abstract

In most cases the fragile X syndrome is caused by an amplification of the CGG trinucleotide repeat in the 5' untranslated region of the FMR1 gene, in combination with the hypermethylation of the proximal CpG island. Recently, also a few cases with deletions or a mosaic of a deletion and a full mutation in the FMR1 gene, leading to the same phenotype, have been described. Here we report the molecular analysis of a patient with typical fragile X phenotype and mosaicism of the FMR1 genomic region consisting of a premutation, a full mutation of the CGG repeats, and a 215 bp deletion, diagnosed by Southern blot hybridisation and polymerase chain reaction (PCR). Sequence analysis of the deletion demonstrated that the 5' breakpoint of the deletion is located within a putative hotspot region 75-53 bp proximal to the CGG repeat.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10331598

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  14 in total

1.  Mutsβ generates both expansions and contractions in a mouse model of the Fragile X-associated disorders.

Authors:  Xiao-Nan Zhao; Daman Kumari; Shikha Gupta; Di Wu; Maya Evanitsky; Wei Yang; Karen Usdin
Journal:  Hum Mol Genet       Date:  2015-09-29       Impact factor: 6.150

2.  The transcription-coupled repair protein ERCC6/CSB also protects against repeat expansion in a mouse model of the fragile X premutation.

Authors:  Xiao-Nan Zhao; Karen Usdin
Journal:  Hum Mutat       Date:  2015-04       Impact factor: 4.878

3.  DNA methylation and replication: implications for the "deletion hotspot" region of FMR1.

Authors:  K Nichol Edamura; C E Pearson
Journal:  Hum Genet       Date:  2005-11-15       Impact factor: 4.132

Review 4.  Mutation spectra in fragile X syndrome induced by deletions of CGG*CCG repeats.

Authors:  Robert D Wells
Journal:  J Biol Chem       Date:  2008-10-28       Impact factor: 5.157

5.  Small genomic rearrangements involving FMR1 support the importance of its gene dosage for normal neurocognitive function.

Authors:  Sandesh C S Nagamani; Ayelet Erez; Frank J Probst; Patricia Bader; Patricia Evans; Linda A Baker; Ping Fang; Terry Bertin; Patricia Hixson; Pawel Stankiewicz; David Nelson; Ankita Patel; Sau Wai Cheung
Journal:  Neurogenetics       Date:  2012-08-14       Impact factor: 2.660

6.  Finding FMR1 mosaicism in Fragile X syndrome.

Authors:  Thaís Fernandez Gonçalves; Jussara Mendonça dos Santos; Andressa Pereira Gonçalves; Flora Tassone; Guadalupe Mendoza-Morales; Márcia Gonçalves Ribeiro; Evelyn Kahn; Raquel Boy; Márcia Mattos Gonçalves Pimentel; Cíntia Barros Santos-Rebouças
Journal:  Expert Rev Mol Diagn       Date:  2016-02-09       Impact factor: 5.225

7.  Size and methylation mosaicism in males with Fragile X syndrome.

Authors:  Poonnada Jiraanont; Madhur Kumar; Hiu-Tung Tang; Glenda Espinal; Paul J Hagerman; Randi J Hagerman; Nuanchan Chutabhakdikul; Flora Tassone
Journal:  Expert Rev Mol Diagn       Date:  2017-11       Impact factor: 5.225

Review 8.  Mosaic FMR1 deletion causes fragile X syndrome and can lead to molecular misdiagnosis: a case report and review of the literature.

Authors:  Bradford Coffee; Morna Ikeda; Dejan B Budimirovic; Lawrence N Hjelm; Walter E Kaufmann; Stephen T Warren
Journal:  Am J Med Genet A       Date:  2008-05-15       Impact factor: 2.802

9.  The mismatch repair protein MSH2 is rate limiting for repeat expansion in a fragile X premutation mouse model.

Authors:  Rachel Adihe Lokanga; Xiao-Nan Zhao; Karen Usdin
Journal:  Hum Mutat       Date:  2014-01       Impact factor: 4.878

10.  BRCA1/2 mutations appear embryo-lethal unless rescued by low (CGG n<26) FMR1 sub-genotypes: explanation for the "BRCA paradox"?

Authors:  Andrea Weghofer; Muy-Kheng Tea; David H Barad; Ann Kim; Christian F Singer; Klaus Wagner; Norbert Gleicher
Journal:  PLoS One       Date:  2012-09-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.